{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Telomir Pharmaceuticals (NASDAQ: TELO) Submits IND for TNBC Candidate Telomir-1

March 31, 2026Telomir Pharmaceuticals (NASDAQ: TELO) announced the submission of an Investigational New Drug application to the FDA for Telomir-1 (Telomir-Zn) targeting advanced and metastatic triple-negative breast cancer, supported by preclinical efficacy and safety data demonstrating tumor growth reduction and favorable tolerability. Pending IND clearance, the company plans to initiate a Phase 1/2 clinical trial evaluating the oral therapy, with a focus on safety, dose optimization and early signs of antitumor activity, as it advances a novel epigenetic approach aimed at addressing significant unmet need in aggressive breast cancer.


Why Crypto Startups Are Struggling to Attract VC Funding

March 31, 2026Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.


More EVs Could Exert Downward Pressure on Gasoline Prices

March 31, 2026The number of electric vehicles on the road is growing steadily, and this shift is beginning to affect more than just the environment. New research shows that increasing the use of electric vehicles, often called EVs, could help lower gasoline prices for everyone, including people who still drive fossil fuel-powered cars.


Oil Shock Triggers Surge in Global Chinese EV Exports

March 31, 2026Surging oil prices are reshaping buying decisions for millions of drivers, and Chinese electric vehicle manufacturers are positioned to benefit the most. Geopolitical instability across the Middle East has pushed crude oil to above $100 per barrel, unsettling fuel markets worldwide.


Cyber Stocks Tumble Amid Reports Anthropic is Testing New AI Model

March 31, 2026Cybersecurity shares fell sharply on March 27 after reports surfaced that Anthropic is testing a new AI system with advanced cyber capabilities and possible security concerns. The way news of Anthropic’s model is spooking investors in cybersecurity firms and other industries shows the disruptive potential of AI and underscores why early movers like Core AI Holdings Inc.


Researchers Discover Mechanism Behind Deadly Pediatric Brain Cancer

March 31, 2026A team of scientists from Texas Children’s Hospital, University of Pittsburgh and Baylor College of Medicine has discovered the primary driver of a deadly pediatric brain cancer, PFA (posterior fossa type A) ependymoma. They identified male sex hormones called androgens as playing a key role in promoting PFA ependymoma growth.


Iran War Highlights How Different Countries are Approaching Renewables

March 31, 2026The war in Iran is exposing something the global energy conversation has consistently glossed over. Different countries are approaching the shift away from fossil fuels from entirely different positions, at entirely different speeds, and with entirely different consequences when disruption hits.


Larry Fink Reconsiders His Crypto Skepticism as BlackRock’s ETF Soars

March 31, 2026Raising venture capital has become more challenging for cryptocurrency startups as investors pull back and tighten their criteria in a cooling market. Sami Start, CEO and founder of crypto infrastructure firm Transak, says the shift marks a clear departure from the previous boom cycle, when funding flowed more freely across the sector.


Michelin Creates New Tires Capable of Boosting EV Range

March 31, 2026Electric vehicle manufacturers are constantly seeking ways to boost how far their models can go on a single charge, and a French tire maker has just come up with new tires that they say can boost EV range. It remains to be seen whether major electric vehicle makers like Tesla Inc.


InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Highlights Buntanetap Development in The Scientist Publication

March 31, 2026Annovis Bio (NYSE: ANVS) announced the publication of an article in The Scientist detailing the discovery and development of its lead drug candidate buntanetap, as the company advances ongoing Phase 3 and extension studies in Alzheimer’s disease and Parkinson’s disease. The company said the article provides historical and scientific context for buntanetap’s progression, with current trials showing approximately 70% enrollment in early Alzheimer’s and 20% enrollment in Parkinson’s, underscoring its focus on advancing neurodegenerative therapies toward key clinical and regulatory milestones.


InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study

March 31, 2026Tonix Pharmaceuticals (NASDAQ: TNXP) announced positive Phase 1 data for TNX-4800, a long-acting monoclonal antibody targeting Borrelia burgdorferi, demonstrating rapid absorption, sustained protective levels for at least four months and a favorable safety profile in healthy subjects. The company said the single-dose subcutaneous therapy could offer a preventative option for Lyme disease, with plans to initiate an adaptive Phase 2 field study in the first half of 2027, pending FDA clearance, to evaluate protection in individuals in endemic areas.